StockData
VNOVOTCWholesale-Apparel, Piece Goods & NotionsFiscal year ends April 30

VitaNova Life Sciences Corp

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026
$4.50+0.50 (+12.50%)

Close on Oct 19, 2026

Market cap
$37.52M
P/E (TTM)
–
Dividend yield
–

About VitaNova Life Sciences

Wholesale-Apparel, Piece Goods & Notions, SIC 5130

VitaNova Life Sciences Corporation is a consumer health, beauty, and lifestyle company that develops, acquires, markets, and sells branded nutritional supplements, functional beverages, and healthy food products. Its core consumer-health operations function under a dual-brand system comprising GeneCode, an advanced science-oriented wellness brand, and AMZ, a high-volume functional-nutrition line. The company also trades healthy food items such as olive juice, white sesame oil, and aloe vera drinks, while maintaining a business consulting segment that advises third parties on funding and management. It primarily serves consumers through a business-to-business model alongside regional distributors and online channels.

The company operates under an asset-light model, relying on third-party contract manufacturers and logistics partners for production and fulfillment. In addition to direct-to-consumer sales in the United States, VitaNova distributes products internationally through cross-border e-commerce platforms. Its principal executive offices are located in New York, New York.

Summary of the business section of VitaNova Life Sciences's latest annual report, written by StockData.

Company profile

Company

Legal name
VitaNova Life Sciences Corp
Founded
2017
Headquarters
New York, NY
Address
39 E. Broadway, Ste 603 10002
Phone
(516) 886-8888
Employees
7, Apr 30, 2026
Industry
Wholesale-Apparel, Piece Goods & Notions
Incorporated in
Nevada
Fiscal year ends
April 30
Auditor
Simon & Edward, LLP, Los Angeles County, California

Stock & identifiers

Ticker
VNOV
Exchange
OTC
IPO date
Apr 13, 2022
Shares outstanding
8M, Sep 14, 2026
Public float
$24.12M, Oct 31, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-3 reverse, Mar 16, 2026; 1-for-3 reverse, Jan 27, 2026
SEC CIK
1699709
EIN
35-2583762

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

No recent ownership filings by officers or directors

VitaNova Life Sciences's leadership is listed in its proxy statement (Form DEF 14A).

Employees

Headcount reported in annual reports

“Annual Report, we had a total of 7 full-time employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Jan 13, 2026Name changeName changed from YIJIA GROUP CORP. to VitaNova Life Sciences Corp
Jun 10, 2024Auditor changeChange in certifying accountant (8-K Item 4.01)
Dec 2, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 11, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 1, 2021Auditor changeChange in certifying accountant (8-K Item 4.01)
Sep 15, 2020Late filingNotification of late filing
Jul 29, 2020Late filingNotification of late filing
Mar 16, 2020Late filingNotification of late filing
Jul 29, 2019Late filingNotification of late filing
Feb 27, 2019Auditor changeChange in certifying accountant (8-K Item 4.01)
Nov 26, 2018Name changeName changed from Soldino Group Corp to YIJIA GROUP CORP
Jul 19, 2018Auditor changeChange in certifying accountant (8-K Item 4.01)
Jun 25, 2018Auditor changeChange in certifying accountant (8-K Item 4.01)